StarchLite® (White Kidney Bean Extract)

Phaseolus vulgaris
Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

StarchLite® is a white kidney bean (Phaseolus vulgaris) extract standardized for phaseolamin, an alpha-amylase inhibitor. By temporarily slowing starch digestion, it reduces the sugar and calories absorbed from starchy meals, supporting weight and carbohydrate management.

Studied Dose Commonly 500 mg to 1 g before starchy meals.
Active Compound White kidney bean (Phaseolus vulgaris) extract containing alpha-amylase-inhibiting phaseolamin.

Benefits

Carbohydrate blocking

By inhibiting starch-digesting alpha-amylase, the extract reduces the sugar and calories absorbed from starchy foods.

Weight management

White kidney bean alpha-amylase inhibitors have supported weight and fat loss in randomized research as part of a calorie-controlled approach.

Post-meal glucose support

Slower starch digestion blunts the rise in blood sugar after a starchy meal.

Mechanism of action

1

Alpha-amylase inhibition

Phaseolamin binds and temporarily inactivates alpha-amylase, slowing the breakdown of starch into absorbable sugars.

2

Reduced caloric absorption

With less starch digested in the small intestine, some passes onward undigested, lowering the meal's effective calorie load.

Clinical trials

1
White Kidney Bean and Weight — RCT
PubMed

12-week double-blind placebo-controlled randomized trial of a white kidney bean alpha-amylase inhibitor on weight and fat loss. (Jäger et al. 2024, Scientific Reports)

Adults.

The white kidney bean inhibitor promoted weight and fat loss versus placebo with acceptable safety.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated — digestive symptoms are most common.
Mild gas, bloating, or loose stools can occur from undigested starch.
Take with starchy meals to assess tolerance.

Important Drug interactions

Diabetes medication — may add to blood-sugar lowering; monitor.
Take with starchy meals, not protein or fat meals, for the intended effect.
Tell your doctor if you manage blood sugar with medication.

Frequently asked questions about StarchLite® (White Kidney Bean Extract)

What is StarchLite?

StarchLite® is a white kidney bean (Phaseolus vulgaris) extract standardized for phaseolamin, an alpha-amylase inhibitor. By temporarily slowing starch digestion, it reduces the sugar and calories absorbed from starchy meals, supporting weight and carbohydrate management.

What is StarchLite used for?

StarchLite is researched primarily for Weight Management and Metabolic Health. By inhibiting starch-digesting alpha-amylase, the extract reduces the sugar and calories absorbed from starchy foods.

What is the recommended dosage of StarchLite?

The clinically studied dose is Commonly 500 mg to 1 g before starchy meals. Always follow the product label and check with a healthcare provider for personal advice.

Is StarchLite safe, and does it have side effects?

For most healthy adults, StarchLite is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — digestive symptoms are most common. Mild gas, bloating, or loose stools can occur from undigested starch. It may also interact with some medications. StarchLite is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does StarchLite interact with any medications?

Possible interactions include: Diabetes medication — may add to blood-sugar lowering; monitor. Take with starchy meals, not protein or fat meals, for the intended effect. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for StarchLite?

NutraSmarts rates the evidence for StarchLite as Limited (2 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Jäger R, Abou Sawan S, Purpura M, et al. Proprietary alpha-amylase inhibitor formulation from white kidney bean (Phaseolus vulgaris L.) promotes weight and fat loss: a 12-week, double-blind, placebo-controlled, randomized trial. Sci Rep. 2024;14(1):12685..PubMedUsed to support: RCT supporting weight benefit of white kidney bean extract (the basis of StarchLite).